Research

The Promise of Precision Medicine

The Promise of Precision Medicine

Posted by  | precision medicine, Research

All cancers are fundamentally disorders of acquired defects in genes. The genes serve as blueprints for all of the components of cells and tissues in the human body. In cancers, faulty blueprints lead to malfunctioning cells that grow uncontrollably, spread throughout the body and overwhelm normal organ functions to threaten life itself. Full realization of(...)

Cancer Research: Back to Basics

Cancer Research: Back to Basics

Posted by  | Research

Many types of cancer are caused by gene mutations acquired during a person’s lifetime. Systematic cataloging of these acquired gene defects has led to improved screening, detection, diagnosis, prevention and treatment.  A more deliberate investment in discovery research could reveal more opportunities for developing cancer treatment by making better sense of the acquired gene defects(...)

2017 in Review: Honors and Awards

2017 in Review: Honors and Awards

Posted by  | Research, Uncategorized

The Kimmel Cancer Center was recognized with many honors and awards in 2017. Here’s the full list: Sidney Kimmel, leading cancer philanthropist for whom the Kimmel Cancer Center is named was honored with the American Association for Cancer Research Distinguished Public Service Award. He was recognized for his lifelong commitment to supporting advances in cancer(...)

What Every Lung Cancer Patient Needs to Know

What Every Lung Cancer Patient Needs to Know

Posted by  | Research, treatment

It’s lung cancer awareness month. “Many times patients come to us and they’ve been told they don’t have hope. We always have hope,” says Peggy Lang, nurse practitioner and coordinator of the Johns Hopkins Kimmel Cancer Center Thoracic Multidisciplinary Clinic and Lung Cancer Screening Program. In this video, she explains what every patient facing a(...)

Stand Up To Cancer Catalyst® Launches 10 Clinical Trial Projects

Stand Up To Cancer Catalyst® Launches 10 Clinical Trial Projects

Posted by  | Research

Johns Hopkins Kimmel Cancer Center researchers and clinicians are among the leaders of one of the 10 Stand Up To Cancer (SU2C) Catalyst® clinical trial projects. Researchers from more than 30 institutions are collaborating across academic and corporate borders on clinical trials aimed at understanding why treatments are effective—across a variety of cancers—in a program(...)

Epigenetic Drugs Reset Genes in Breast, Colon Cancers But Didn’t Shrink Tumors

Posted by  | Research, treatment

--Two clinical trials suggest promise for using these medications in combination with other cancer therapies Two clinical trials using combinations of drugs meant to change cancer epigentics —or the way tumors express genes — failed at shrinking colon and breast tumors. However, these trials open the door for others currently in the works to combine(...)